In addition, the normal mucosa of healthy MMR PV/LPV carriers has been shown to contain an increased average abundance of CD3-, CD8-, and FOXP3-positive immune cells40 compared with LS cancer patients and proficient MMR cancer patients, and that time to CRC development is correlated to the relative abundance of these immune cells41. The gene discussed is FOXP3; the disease is cancer.